Andén N E, Grabowska-Andén M
Department of Pharmacology, Karolinska Institute, Stockholm, Sweden.
Acta Physiol Scand. 1988 Oct;134(2):285-90. doi: 10.1111/j.1748-1716.1988.tb08490.x.
Possible postsynaptic effects of the preferential dopamine autoreceptor agonist B-HT 920 were studied by means of the mouse motor activity. In reserpine-treated mice, B-HT 920 did not cause any motor activity by itself but it markedly potentiated the slight stimulating effect of the D1 dopamine agonist SKF 38 393. The effect was blocked by either the D2-receptor antagonist sulpiride or the D1-receptor antagonist SCH 23 390, indicating that motor activity is dependent on simultaneous activation of both dopamine receptor types. The hyperactivity produced by 0.1 mg kg-1 B-HT 920 in combination with SKF 38 393 in reserpine-treated mice was at least as great as that following a maximal dose of apomorphine, indicating that B-HT 920 is a full agonist at postsynaptic D2 receptors. The effect of 0.1 mg kg-1 B-HT 920 peaked earlier than those of 1 mg kg-1 and particularly, 10 mg kg-1 suggesting additional effects of the later two doses. B-HT 920 stimulates dopamine autoreceptors almost maximally following 0.1 or 1 mg kg-1 but only the latter dose (with or without SKF 38 393) caused hyperactivity of mice not treated with reserpine. This finding indicates that the postsynaptic D2 receptors are less sensitive to B-HT 920 than the D2 dopamine autoreceptors.
通过小鼠运动活性研究了选择性多巴胺自身受体激动剂B-HT 920可能的突触后效应。在利血平处理的小鼠中,B-HT 920自身不会引起任何运动活性,但它能显著增强D1多巴胺激动剂SKF 38393的轻微刺激作用。该效应被D2受体拮抗剂舒必利或D1受体拮抗剂SCH 23390阻断,表明运动活性依赖于两种多巴胺受体类型的同时激活。在利血平处理的小鼠中,0.1mg/kg的B-HT 920与SKF 38393联合产生的多动至少与最大剂量阿扑吗啡后的多动程度相同,表明B-HT 920是突触后D2受体的完全激动剂。0.1mg/kg的B-HT 920的效应比1mg/kg尤其是10mg/kg的效应峰值出现得更早,提示后两种剂量有额外的效应。0.1或1mg/kg的B-HT 920几乎能最大程度地刺激多巴胺自身受体,但只有后一剂量(无论有无SKF 38393)能使未用利血平处理的小鼠出现多动。这一发现表明,突触后D2受体对B-HT 920的敏感性低于D2多巴胺自身受体。